首页 > 最新文献

Journal of Experimental Therapeutics and Oncology最新文献

英文 中文
Clear cell variant of Oral Squamous cell carcinoma. 口腔鳞状细胞癌的透明细胞变异。
Q3 Pharmacology, Toxicology and Pharmaceutics Pub Date : 2019-12-01
Priya Sahni, Neetu Sinha, Rajesh Kumar, Aanchal Sharma

Objective: Among the various histopathological variants of oral squamous cell carcinoma, clear cell variant is a rarity. (1) This report is a compilation of two cases which showed the presence of clear cells. The clear cells were of koilocytic type. Although clear cell variant of squamous cell carcinoma is more common in skin, few cases have been found in oral region also. (2) This variant is considered more aggressive than the others, and hence requires more aggressive treatment protocol. Being rare, the percentage of clear cells determines whether it should be considered as a clear cell variant. The literature has been evaluated for similar cases, and discussed about the clear cells and their origin. An effort has also been made to compile the reported cases of clear cell variant of OSCC.

目的:在口腔鳞状细胞癌的各种组织病理变异中,透明细胞变异是一种罕见的变异。这份报告是对两个显示有透明细胞的病例的汇编。透明细胞为空心细胞型。虽然透明细胞型鳞状细胞癌多见于皮肤,但在口腔也很少发现。(2)这种变体被认为比其他变体更具侵袭性,因此需要更积极的治疗方案。由于其罕见,透明细胞的百分比决定了是否应将其视为透明细胞变异。对类似病例的文献进行了评价,并对透明细胞及其来源进行了讨论。我们还努力汇编已报道的透明细胞型OSCC病例。
{"title":"Clear cell variant of Oral Squamous cell carcinoma.","authors":"Priya Sahni,&nbsp;Neetu Sinha,&nbsp;Rajesh Kumar,&nbsp;Aanchal Sharma","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Objective: </strong>Among the various histopathological variants of oral squamous cell carcinoma, clear cell variant is a rarity. (1) This report is a compilation of two cases which showed the presence of clear cells. The clear cells were of koilocytic type. Although clear cell variant of squamous cell carcinoma is more common in skin, few cases have been found in oral region also. (2) This variant is considered more aggressive than the others, and hence requires more aggressive treatment protocol. Being rare, the percentage of clear cells determines whether it should be considered as a clear cell variant. The literature has been evaluated for similar cases, and discussed about the clear cells and their origin. An effort has also been made to compile the reported cases of clear cell variant of OSCC.</p>","PeriodicalId":45335,"journal":{"name":"Journal of Experimental Therapeutics and Oncology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2019-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"37494192","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effectiveness of structured teaching programme on knowledge and practice regarding care of children with leukemia among mothers. 有关母亲照顾白血病儿童的知识和实践的结构化教学计划的成效。
Q3 Pharmacology, Toxicology and Pharmaceutics Pub Date : 2019-12-01
Varshini Priya, Anita David, D Geetha

Objective: Since, it is essential to create awareness about chemotherapy among parents, this study assesses the effectiveness of structured teaching programme for mothers on knowledge and practice relating to care of child with leukemia. Pretest was conducted using structured questionnaire on knowledge about care of Leukemia. Teaching was administered to mothers on different aspects of cancer diagnosis and follow up. There was a statistically significant difference in knowledge and practice in post test and a significant correlation of knowledge and practice in post test, but not during pre test. Considering different aspects of care, mothers had only around 50 % knowledge which was close to 100 % post test. The study revealed that there was a significant association between knowledge with age of the child and number of the children, and in practice, association was found in gender of the child and the educational status of the mother. The current study results proved that willingness of parents to receive educational intervention on care of children with Acute Lymphoblastic Leukemia would definitely result in improvement of the quality of life of childhood survivors.

目的:由于提高家长对化疗的认识是至关重要的,本研究评估了为母亲提供有关白血病儿童护理知识和实践的结构化教学计划的有效性。前测采用结构化问卷对白血病护理知识进行调查。对母亲们进行了癌症诊断和随访的不同方面的教学。后测中知识与实践的差异有统计学意义,后测中知识与实践的相关有统计学意义,前测中知识与实践的相关无统计学意义。考虑到护理的不同方面,母亲只有大约50%的知识,而测试后接近100%。研究发现,知识与孩子的年龄和孩子的数量之间存在显著的关联,而在实践中,孩子的性别与母亲的受教育程度之间存在关联。目前的研究结果证明,父母愿意接受急性淋巴细胞白血病儿童护理的教育干预,肯定会改善儿童幸存者的生活质量。
{"title":"Effectiveness of structured teaching programme on knowledge and practice regarding care of children with leukemia among mothers.","authors":"Varshini Priya,&nbsp;Anita David,&nbsp;D Geetha","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Objective: </strong>Since, it is essential to create awareness about chemotherapy among parents, this study assesses the effectiveness of structured teaching programme for mothers on knowledge and practice relating to care of child with leukemia. Pretest was conducted using structured questionnaire on knowledge about care of Leukemia. Teaching was administered to mothers on different aspects of cancer diagnosis and follow up. There was a statistically significant difference in knowledge and practice in post test and a significant correlation of knowledge and practice in post test, but not during pre test. Considering different aspects of care, mothers had only around 50 % knowledge which was close to 100 % post test. The study revealed that there was a significant association between knowledge with age of the child and number of the children, and in practice, association was found in gender of the child and the educational status of the mother. The current study results proved that willingness of parents to receive educational intervention on care of children with Acute Lymphoblastic Leukemia would definitely result in improvement of the quality of life of childhood survivors.</p>","PeriodicalId":45335,"journal":{"name":"Journal of Experimental Therapeutics and Oncology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2019-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"37495267","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Giant Cervicodorsal Schwannoma. 巨大颈鼻神经鞘瘤。
Q3 Pharmacology, Toxicology and Pharmaceutics Pub Date : 2019-12-01
Sudha Ram, V Vivek, Ravi Shekhar, Abhirama Chandra Gabbita, K Ganesh

Objective: Schwannomas are benign slow growing tumors that arise from myelin producing Schwann cells. Schwannomas developing in cervical-dorsal region are rare benign neoplasms which are emerges leisurely remains asymptomatic some times and functionally inactive tumours. Giant Schwannomas extending over two or more vertebral levels have been documented and attempts have been made to classify these in available literature, however inadequate. Advancement in imaging modalities and microsurgery has bettered management of these tumors. A rare case of intradural extramedullary cervicodorsal schwannoma extending along seven vertebral levels to thoracic levels is reported in a 55 year old male patient with progressive weakness and numbness of over one and a half years. MRI of cervical spine showed a heterogeneously lesion with cord oedema till D7 level on T1contrast saggital view. Histological examination revealed encapsulated spindle cell lesion with hypocellular and hypercellular areas with verucay bodies, occasional bizzare nuclei, hyalinized blood vessels, with no evidence of necrosis/atypical mitosis, suggestive of schwannoma. In the prone position, C4 to D7 enbloc laminotomy was done and total excision of intradural extramedullary lesion was done. Post-operative CT scans revealed normal spinal canal dimensions with implants in situ. At quarterly follow up upto one year post-operative, the patient had near normal power in all four limbs and normal bladder function.

目的:神经鞘瘤是由产生髓磷脂的雪旺细胞引起的生长缓慢的良性肿瘤。颈背神经鞘瘤是一种罕见的良性肿瘤,发病缓慢,有时无症状,功能不活跃。巨大的神经鞘瘤延伸超过两个或两个以上的椎体水平已被记录,并试图在现有文献中对其进行分类,但不充分。影像方式和显微外科的进步使这些肿瘤的治疗变得更好。本文报告一例罕见的硬膜内髓外颈背神经鞘瘤,沿7个椎体水平延伸至胸椎水平,患者为55岁男性,进行性虚弱和麻木超过一年半。颈椎MRI在t1矢状位上显示病变不均一,脊髓水肿至D7水平。组织学检查显示包裹性梭形细胞病变,伴细胞少或细胞多区,胞体,偶见奇异核,血管透明,无坏死/非典型有丝分裂,提示神经鞘瘤。俯卧位,行C4至D7椎板闭合切开术,全部切除硬膜内髓外病变。术后CT扫描显示椎管尺寸正常,植入物原位。术后每季度随访一年,患者四肢力量接近正常,膀胱功能正常。
{"title":"Giant Cervicodorsal Schwannoma.","authors":"Sudha Ram,&nbsp;V Vivek,&nbsp;Ravi Shekhar,&nbsp;Abhirama Chandra Gabbita,&nbsp;K Ganesh","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Objective: </strong>Schwannomas are benign slow growing tumors that arise from myelin producing Schwann cells. Schwannomas developing in cervical-dorsal region are rare benign neoplasms which are emerges leisurely remains asymptomatic some times and functionally inactive tumours. Giant Schwannomas extending over two or more vertebral levels have been documented and attempts have been made to classify these in available literature, however inadequate. Advancement in imaging modalities and microsurgery has bettered management of these tumors. A rare case of intradural extramedullary cervicodorsal schwannoma extending along seven vertebral levels to thoracic levels is reported in a 55 year old male patient with progressive weakness and numbness of over one and a half years. MRI of cervical spine showed a heterogeneously lesion with cord oedema till D7 level on T1contrast saggital view. Histological examination revealed encapsulated spindle cell lesion with hypocellular and hypercellular areas with verucay bodies, occasional bizzare nuclei, hyalinized blood vessels, with no evidence of necrosis/atypical mitosis, suggestive of schwannoma. In the prone position, C4 to D7 enbloc laminotomy was done and total excision of intradural extramedullary lesion was done. Post-operative CT scans revealed normal spinal canal dimensions with implants in situ. At quarterly follow up upto one year post-operative, the patient had near normal power in all four limbs and normal bladder function.</p>","PeriodicalId":45335,"journal":{"name":"Journal of Experimental Therapeutics and Oncology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2019-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"37494191","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cervical carcinosarcoma presented in advanced stage after high grade cervical displasia. 宫颈高度增生后出现的晚期宫颈癌肉瘤。
Q3 Pharmacology, Toxicology and Pharmaceutics Pub Date : 2019-12-01
Volkan Karataşlı, Selçuk Erkılınç, Behzat Can, İlker Çakır, Orhan Temel, Mehmet Gökçü, Muzaffer Sancı

Objective: Cervical carcinosarcomas (Malignant Mixed Mullerian Tumour [MMMT] ) are very rare neoplasms. Fewer than 100 cases were documented until recently. Because of the rarity, etiologic factors, prognosis and treatment modalities are unclear. A 53 year-old woman presented with postmenauposal vaginal bleeding and abnormal cervical cytology. Cervical biopsy followed by loop electrosurgical excision procedure (LEEP) and cold knife conisation (CKC) was documented as cervical intraepithelial neoplasia III (CIN III). Without follow-up, two years later, the patient was referred with a cervical 6,5 cm mass invading vagina, parametriums and rectum. Biopsy was reported as cervical carcinosarcoma with squmous carcinoma and homologous sarcoma component. Neoadjuvant chemotherapy provided partial response. Subsequently external beam whole pelvis radiotherapy with chemotherapy and brachytherapy was applied. In despite of the treatment, the patient developed sistemic recurrence and died of disease within 10 months. In previous reports most of the patients were in early stage and had better prognosis than uterine carcinosarcomas. Here in we present a case who had a history of high-grade cervical displasia and presented at advanced stage, managed with neoadjuvant chemotherapy and definitive chemoradiotherapy.

目的:宫颈癌肉瘤(恶性混合苗勒氏瘤)是一种非常罕见的肿瘤。直到最近,记录在案的病例还不到100例。由于罕见,病因、预后和治疗方式尚不清楚。一个53岁的妇女提出了绝经后阴道出血和宫颈细胞学异常。宫颈活检后行环形电切术(LEEP)和冷刀锥切术(CKC),记录为宫颈上皮内瘤变III (CIN III)。未随访,两年后,患者因宫颈6,5 cm肿块侵入阴道,参数和直肠而转诊。活检报告为宫颈癌肉瘤伴鳞状癌和同源肉瘤成分。新辅助化疗提供部分缓解。随后行全骨盆外束放疗加近距离化疗。尽管接受了治疗,但患者出现了系统性复发,并在10个月内死于疾病。在以往的报道中,大多数患者处于早期,预后优于子宫癌肉瘤。在这里,我们提出了一个病例,他有高度宫颈增生的历史,并在晚期提出,与新辅助化疗和明确放化疗管理。
{"title":"Cervical carcinosarcoma presented in advanced stage after high grade cervical displasia.","authors":"Volkan Karataşlı,&nbsp;Selçuk Erkılınç,&nbsp;Behzat Can,&nbsp;İlker Çakır,&nbsp;Orhan Temel,&nbsp;Mehmet Gökçü,&nbsp;Muzaffer Sancı","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Objective: </strong>Cervical carcinosarcomas (Malignant Mixed Mullerian Tumour [MMMT] ) are very rare neoplasms. Fewer than 100 cases were documented until recently. Because of the rarity, etiologic factors, prognosis and treatment modalities are unclear. A 53 year-old woman presented with postmenauposal vaginal bleeding and abnormal cervical cytology. Cervical biopsy followed by loop electrosurgical excision procedure (LEEP) and cold knife conisation (CKC) was documented as cervical intraepithelial neoplasia III (CIN III). Without follow-up, two years later, the patient was referred with a cervical 6,5 cm mass invading vagina, parametriums and rectum. Biopsy was reported as cervical carcinosarcoma with squmous carcinoma and homologous sarcoma component. Neoadjuvant chemotherapy provided partial response. Subsequently external beam whole pelvis radiotherapy with chemotherapy and brachytherapy was applied. In despite of the treatment, the patient developed sistemic recurrence and died of disease within 10 months. In previous reports most of the patients were in early stage and had better prognosis than uterine carcinosarcomas. Here in we present a case who had a history of high-grade cervical displasia and presented at advanced stage, managed with neoadjuvant chemotherapy and definitive chemoradiotherapy.</p>","PeriodicalId":45335,"journal":{"name":"Journal of Experimental Therapeutics and Oncology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2019-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"37494193","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clinico-pathological presentation of breast carcinoma and its correlation with β hCG. 乳腺癌的临床病理表现及其与β hCG的关系。
Q3 Pharmacology, Toxicology and Pharmaceutics Pub Date : 2019-12-01
Anjana Vasudevan, Ponniah Iyyappan, C Kaliyappa, K Balaji Singh

Background: The pathophysiological role of HCG is currently speculative and seems to be paradoxes as certain studies advice it has anti-cancer properties while few others found it to be pro-cancer agent. In this study we have evaluated the status of beta hCG receptors in patients with breast carcinoma and its association with various clinic-pathological factors.

Methods: A cross-sectional study was conducted on total of 57 patients who were enrolled in the study, all tests including metastatic work up were done. Patients underwent modified radical mastectomy on the affected side after being declared fit by the anaesthetist. Immunohistochemical analysis was done using ER antibody, PR88, CB11 and for beta hCG was done using ab-53087.

Results: The average age at diagnosis was 55.77 years. There was a significant correlation between age at diagnosis and age at first child birth. On correlating size of the tumour with Beta hCG receptor status, Patients with tumour size 2 to 5 cms have shown maximum positivity for beta hCG receptors. On correlating stage of the disease with Beta HCG receptor status, it was found that, carcinoma tissues showed more receptor positivity as the stage increased. In histological staining grade, Nottingham's scoring system was used which showed majority of patients belonged to grade 2.

Discussion: Comparison of other tumour characteristics such as histopathological type, grade, tumour size and nodal status were similar among the studies done in Western and Indian regions. The similarities of the current as well as the above mentioned Indian studies with Western countries could be attributed to increasing awareness and better screening protocols for breast carcinoma.

背景:HCG的病理生理作用目前是推测性的,似乎是矛盾的,因为某些研究表明它具有抗癌特性,而少数其他研究发现它是促癌剂。在这项研究中,我们评估了- hCG受体在乳腺癌患者中的地位及其与各种临床病理因素的关系。方法:横断面研究共对57例纳入研究的患者进行,包括转移性工作在内的所有测试都完成了。病人接受改良根治性乳房切除术后,由麻醉师宣布适合患侧。使用ER抗体、PR88、CB11进行免疫组化分析,使用ab-53087进行β - hCG分析。结果:平均诊断年龄55.77岁。诊断年龄与第一胎年龄有显著的相关性。关于肿瘤大小与β - hCG受体状态的相关性,肿瘤大小为2 - 5cm的患者β - hCG受体阳性最多。在将疾病分期与β - HCG受体状态相关联时,发现随着分期的增加,癌组织中β - HCG受体呈阳性。组织学染色分级采用Nottingham评分系统,多数患者属于2级。讨论:在西方和印度地区进行的研究中,其他肿瘤特征的比较,如组织病理类型、分级、肿瘤大小和淋巴结状态相似。印度目前的研究以及上述研究与西方国家的相似之处可归因于对乳腺癌认识的提高和更好的筛查方案。
{"title":"Clinico-pathological presentation of breast carcinoma and its correlation with β hCG.","authors":"Anjana Vasudevan,&nbsp;Ponniah Iyyappan,&nbsp;C Kaliyappa,&nbsp;K Balaji Singh","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Background: </strong>The pathophysiological role of HCG is currently speculative and seems to be paradoxes as certain studies advice it has anti-cancer properties while few others found it to be pro-cancer agent. In this study we have evaluated the status of beta hCG receptors in patients with breast carcinoma and its association with various clinic-pathological factors.</p><p><strong>Methods: </strong>A cross-sectional study was conducted on total of 57 patients who were enrolled in the study, all tests including metastatic work up were done. Patients underwent modified radical mastectomy on the affected side after being declared fit by the anaesthetist. Immunohistochemical analysis was done using ER antibody, PR88, CB11 and for beta hCG was done using ab-53087.</p><p><strong>Results: </strong>The average age at diagnosis was 55.77 years. There was a significant correlation between age at diagnosis and age at first child birth. On correlating size of the tumour with Beta hCG receptor status, Patients with tumour size 2 to 5 cms have shown maximum positivity for beta hCG receptors. On correlating stage of the disease with Beta HCG receptor status, it was found that, carcinoma tissues showed more receptor positivity as the stage increased. In histological staining grade, Nottingham's scoring system was used which showed majority of patients belonged to grade 2.</p><p><strong>Discussion: </strong>Comparison of other tumour characteristics such as histopathological type, grade, tumour size and nodal status were similar among the studies done in Western and Indian regions. The similarities of the current as well as the above mentioned Indian studies with Western countries could be attributed to increasing awareness and better screening protocols for breast carcinoma.</p>","PeriodicalId":45335,"journal":{"name":"Journal of Experimental Therapeutics and Oncology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2019-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"37495266","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Phase II study of bevacizumab, cisplatin, and pemetrexed in advanced non-squamous non-small cell lung cancer (NS-NSCLC) with EGFR wild-type. 贝伐单抗、顺铂和培美曲塞治疗EGFR野生型晚期非鳞状非小细胞肺癌(NS-NSCLC)的II期研究
Q3 Pharmacology, Toxicology and Pharmaceutics Pub Date : 2019-12-01
Shuji Murakami, Haruhiro Saito, Tetsuro Kondo, Fumihiro Oshita, Kouzo Yamada

Background: Continuation maintenance therapy with pemetrexed (PEM) and bevacizumab (BEV) following induction therapy with cisplatin (CDDP), PEM, and BEV is beneficial in advanced non-squamous non-small-cell lung cancer (NS-NSCLC), but the survival benefit of addition of BEV to CDDP/PEM as induction therapy is still unclear. The aim of this phase II study was to evaluate the feasibility and safety of a CDDP/PEM/BEV regimen in Japanese patients with EGFR wild-type NS-NSCLC.

Patients and methods: This study included 25 patients who receive intravenous CDDP, PEM, and BEV (15 mg/kg) from August 2010 to February 2013. The primary endpoint of this study was the response rate (RR) and the secondary endpoint was progression free survival (PFS), overall survival (OS), and safety.

Results: The median cycles of induction chemotherapy were four (range 1-6). RR was 64%. Most patients (64%) transitioned to maintenance therapy. The median PFS was 9.7 months. Median OS was 21.6 months. Haematological adverse events reaching grade 3 to 4 were neutropenia (8%) without febrile neutropenia, thrombocytopenia (4%), and anemia (4%). BEV-related non-haematological toxicities of grade 3/4 were hypertension (16%), thrombosis (4%), and gastrointestinal perforation (4%). Each adverse events was controllable, and there were no treatment-related deaths.

Conclusions: CDDP/PEM/BEV regimen is effective and tolerable in patients with EGFR wild-type advanced NS-NSCLC, but should be paid attention to some BEV-related toxicities.

背景:顺铂(CDDP)、PEM和BEV诱导治疗后继续使用培美曲塞(PEM)和贝伐单抗(BEV)维持治疗对晚期非鳞状非小细胞肺癌(NS-NSCLC)有益,但BEV在CDDP/PEM诱导治疗后的生存获益尚不清楚。这项II期研究的目的是评估CDDP/PEM/BEV方案在日本EGFR野生型NS-NSCLC患者中的可行性和安全性。患者和方法:本研究纳入了2010年8月至2013年2月接受静脉注射CDDP、PEM和BEV (15mg /kg)的25例患者。该研究的主要终点是缓解率(RR),次要终点是无进展生存期(PFS)、总生存期(OS)和安全性。结果:诱导化疗的中位周期为4个(范围1-6)。RR为64%。大多数患者(64%)过渡到维持治疗。中位PFS为9.7个月。中位OS为21.6个月。达到3 - 4级的血液学不良事件包括无发热性中性粒细胞减少症(8%)、血小板减少症(4%)和贫血(4%)。3/4级bev相关的非血液学毒性包括高血压(16%)、血栓形成(4%)和胃肠道穿孔(4%)。所有不良事件均可控,无治疗相关死亡。结论:CDDP/PEM/BEV方案对EGFR野生型晚期NS-NSCLC患者有效且耐受,但应注意BEV相关的一些毒性。
{"title":"Phase II study of bevacizumab, cisplatin, and pemetrexed in advanced non-squamous non-small cell lung cancer (NS-NSCLC) with EGFR wild-type.","authors":"Shuji Murakami,&nbsp;Haruhiro Saito,&nbsp;Tetsuro Kondo,&nbsp;Fumihiro Oshita,&nbsp;Kouzo Yamada","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Background: </strong>Continuation maintenance therapy with pemetrexed (PEM) and bevacizumab (BEV) following induction therapy with cisplatin (CDDP), PEM, and BEV is beneficial in advanced non-squamous non-small-cell lung cancer (NS-NSCLC), but the survival benefit of addition of BEV to CDDP/PEM as induction therapy is still unclear. The aim of this phase II study was to evaluate the feasibility and safety of a CDDP/PEM/BEV regimen in Japanese patients with EGFR wild-type NS-NSCLC.</p><p><strong>Patients and methods: </strong>This study included 25 patients who receive intravenous CDDP, PEM, and BEV (15 mg/kg) from August 2010 to February 2013. The primary endpoint of this study was the response rate (RR) and the secondary endpoint was progression free survival (PFS), overall survival (OS), and safety.</p><p><strong>Results: </strong>The median cycles of induction chemotherapy were four (range 1-6). RR was 64%. Most patients (64%) transitioned to maintenance therapy. The median PFS was 9.7 months. Median OS was 21.6 months. Haematological adverse events reaching grade 3 to 4 were neutropenia (8%) without febrile neutropenia, thrombocytopenia (4%), and anemia (4%). BEV-related non-haematological toxicities of grade 3/4 were hypertension (16%), thrombosis (4%), and gastrointestinal perforation (4%). Each adverse events was controllable, and there were no treatment-related deaths.</p><p><strong>Conclusions: </strong>CDDP/PEM/BEV regimen is effective and tolerable in patients with EGFR wild-type advanced NS-NSCLC, but should be paid attention to some BEV-related toxicities.</p>","PeriodicalId":45335,"journal":{"name":"Journal of Experimental Therapeutics and Oncology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2019-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"37495265","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Mebendazole in simultaneous combination with dexamethasone-(C21-phosphoramidate)-[anti-EGFR] generated utilizing a novel synthesis regimen: dual anti-neoplastic cytotoxicity against pulmonary adenocarcinoma (A549). 甲苯达唑与地塞米松-(c21 -酰胺)-[抗egfr]同时联合使用一种新的合成方案:双重抗肿瘤细胞毒性肺腺癌(A549)。
Q3 Pharmacology, Toxicology and Pharmaceutics Pub Date : 2019-12-01
C P Coyne, Lakshmi Narayanan

Purpose: The short and long-term resolution of neoplastic conditions with conventional low molecular weight chemotherapeutics is frequently restricted by limitations associated dose-dependent toxic sequelae. Penetration into neoplastic cells occurs non-selectively where their intracellular concentration following simple passive diffusion from the extracellular fluid compartment becomes essentially equivalent to levels found in normal healthy cell populations residing within tissues and organ systems. Selective "targeted" delivery of conventional low molecular weight chemotherapeutics represents one molecular strategy that can both increase potency and reduce dose-dependent toxic sequela. A second strategy is the identification of synergistic or additive combinations of chemotherapeutics and pharmaceutical agents, in addition to the discovery of re-purposed pharmaceutical agents that possess anti-cancer properties.

Discussion: Mebendazole evoked anti-neoplastic cytotoxicity as both a single entity, and contributed to the potency of the covalent immunoglucocorticoid, dexamethasone-(C21-phosphoramidate)-[anti-EGFR] when applied in a dual-combination challenge against populations of pulmonary adenocarcinoma (A549). In this capacity mebendazole demonstrated a role as a candidate re-purposed pharmaceutical that possessing potential as a [-i-] substitute alternative for conventional tubulin inhibitors in scenarios of idiosyncratic reactions, therapeutic resistance, or anticipated toxic sequelae; [-ii-] a new monotherapy; or [-iii-] a component in the design of new multi-therapeutic protocols.

目的:常规低分子化疗的短期和长期解决肿瘤条件经常受到相关剂量依赖性毒性后遗症的限制。在细胞外液简单被动扩散后,其细胞内浓度基本上等同于组织和器官系统内正常健康细胞群的水平,此时非选择性地渗透到肿瘤细胞中。传统低分子量化疗药物的选择性“靶向”递送代表了一种既可以提高效力又可以减少剂量依赖性毒性后遗症的分子策略。第二种策略是确定化疗药物和药物的协同或添加剂组合,以及发现具有抗癌特性的重新用途的药物。讨论:甲苯达唑作为一个单一的实体引起了抗肿瘤细胞毒性,并且当用于肺腺癌人群的双重联合攻击时,有助于共价免疫糖皮质激素地塞米松-(c21 -酰胺)-[抗egfr]的效力(A549)。在这种情况下,甲苯达唑证明了作为一种候选的重新用途药物的作用,在特殊反应、治疗耐药性或预期的毒性后遗症的情况下,它具有作为传统微管蛋白抑制剂的[-i-]替代品的潜力;[-ii-]一种新的单一疗法;或者[-iii-]是设计新的多治疗方案的一个组成部分。
{"title":"Mebendazole in simultaneous combination with dexamethasone-(C<sub>21</sub>-phosphoramidate)-[anti-EGFR] generated utilizing a novel synthesis regimen: dual anti-neoplastic cytotoxicity against pulmonary adenocarcinoma (A549).","authors":"C P Coyne,&nbsp;Lakshmi Narayanan","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Purpose: </strong>The short and long-term resolution of neoplastic conditions with conventional low molecular weight chemotherapeutics is frequently restricted by limitations associated dose-dependent toxic sequelae. Penetration into neoplastic cells occurs non-selectively where their intracellular concentration following simple passive diffusion from the extracellular fluid compartment becomes essentially equivalent to levels found in normal healthy cell populations residing within tissues and organ systems. Selective \"targeted\" delivery of conventional low molecular weight chemotherapeutics represents one molecular strategy that can both increase potency and reduce dose-dependent toxic sequela. A second strategy is the identification of synergistic or additive combinations of chemotherapeutics and pharmaceutical agents, in addition to the discovery of re-purposed pharmaceutical agents that possess anti-cancer properties.</p><p><strong>Discussion: </strong>Mebendazole evoked anti-neoplastic cytotoxicity as both a single entity, and contributed to the potency of the covalent immunoglucocorticoid, dexamethasone-(C<sub>21</sub>-phosphoramidate)-[anti-EGFR] when applied in a dual-combination challenge against populations of pulmonary adenocarcinoma (A549). In this capacity mebendazole demonstrated a role as a candidate re-purposed pharmaceutical that possessing potential as a [-i-] substitute alternative for conventional tubulin inhibitors in scenarios of idiosyncratic reactions, therapeutic resistance, or anticipated toxic sequelae; [-ii-] a new monotherapy; or [-iii-] a component in the design of new multi-therapeutic protocols.</p>","PeriodicalId":45335,"journal":{"name":"Journal of Experimental Therapeutics and Oncology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2019-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"37495262","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Glandular odontogenic cyst: a case report in an asymptomatic patient. 腺性牙源性囊肿:无症状患者1例报告。
Q3 Pharmacology, Toxicology and Pharmaceutics Pub Date : 2019-12-01
Gokul Venkateshwar, Sandhya Tamgadge, Avinash Tamgadge, Treville Pereira

Objective: Glandular odontogenic cyst is an extremely rare lesion of the jaw. Its aggressive behavior and high recurrence rate makes it important while excising. Both clinical and radiographic features were nonspecific due to the similarities with other lesions therefore it can be misdiagnosed very easily. This article presents another case of Glandular odontogenic cyst in 17 year of male patient who was unaware of the lesion which was detected on routine examination.

目的:腺源性牙源性囊肿是一种极为罕见的颌骨病变。它的侵袭性和高复发率使其在切除时变得重要。由于与其他病变相似,临床和影像学表现均无特异性,极易误诊。本文报告另一例17岁男性腺源性牙源性囊肿,他在常规检查中未发现病变。
{"title":"Glandular odontogenic cyst: a case report in an asymptomatic patient.","authors":"Gokul Venkateshwar,&nbsp;Sandhya Tamgadge,&nbsp;Avinash Tamgadge,&nbsp;Treville Pereira","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Objective: </strong>Glandular odontogenic cyst is an extremely rare lesion of the jaw. Its aggressive behavior and high recurrence rate makes it important while excising. Both clinical and radiographic features were nonspecific due to the similarities with other lesions therefore it can be misdiagnosed very easily. This article presents another case of Glandular odontogenic cyst in 17 year of male patient who was unaware of the lesion which was detected on routine examination.</p>","PeriodicalId":45335,"journal":{"name":"Journal of Experimental Therapeutics and Oncology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2019-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"37494194","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A study on the efficacy of single layer full thickness duct to mucosa pancreatojejunostomy following pancreatoduodenectomy. 单层全厚导管在胰十二指肠切除术后粘膜胰空肠吻合术中的应用。
Q3 Pharmacology, Toxicology and Pharmaceutics Pub Date : 2019-12-01
Sankar Subramanian, P Sureshkumar, Jagan Balu

Objective: Pancreatoduodenectomy is the procedure of choice for treating periampullary and pancreatic head malignancy. The procedure has been standardized and the mortality has reduced considerably to fewer than 5% in high volume centers specializing in pancreatic surgeries. Unfortunately, the morbidity still hovers around 40%. The Achiles heal of pancreatoduodenectomy is the pancreatoenteric anastamosis, the failure of which leads to significant morbidity. Literature is flooded with a plethora of techniques of reconstruction, and the results are variable. In this present study, we have analyzed a technique in which we used a single layer full thickness duct to mucosa pancreatojejunostomy. Among the 25 subjects in this study, there was only one case of one mortality due to drug-induced cardiac arrhythmia, and no mortality secondary to pancreas-specific complications were reported. The present study was a pilot study compared with historical controls, where these results were comparable to the historical data reported earlier as well as our own historical data of two-layered anastamosis. The results of this pilot study supported our concept of single layer full thickness duct to mucosa anastamosis being least traumatic to the pancreas and having an equal efficacy to that other conventional techniques.

目的:胰十二指肠切除术是治疗壶腹周围及胰头恶性肿瘤的首选手术方式。手术已经标准化,在专门从事胰腺手术的大容量中心,死亡率已大大降低到5%以下。不幸的是,发病率仍然徘徊在40%左右。胰十二指肠切除术的主要治疗方法是胰肠吻合术,胰肠吻合术的失败会导致严重的并发症。文学中充斥着过多的重构技术,其结果是多变的。在本研究中,我们分析了一种使用单层全层导管进行粘膜胰空肠吻合术的技术。本研究25例受试者中,仅有1例因药物性心律失常死亡,无胰脏特异性并发症继发死亡报告。本研究是一项与历史对照比较的初步研究,其结果与先前报道的历史数据以及我们自己的两层吻合的历史数据相当。这项初步研究的结果支持了我们的概念,即单层全层导管与粘膜吻合对胰腺的创伤最小,并且与其他传统技术具有相同的疗效。
{"title":"A study on the efficacy of single layer full thickness duct to mucosa pancreatojejunostomy following pancreatoduodenectomy.","authors":"Sankar Subramanian,&nbsp;P Sureshkumar,&nbsp;Jagan Balu","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Objective: </strong>Pancreatoduodenectomy is the procedure of choice for treating periampullary and pancreatic head malignancy. The procedure has been standardized and the mortality has reduced considerably to fewer than 5% in high volume centers specializing in pancreatic surgeries. Unfortunately, the morbidity still hovers around 40%. The Achiles heal of pancreatoduodenectomy is the pancreatoenteric anastamosis, the failure of which leads to significant morbidity. Literature is flooded with a plethora of techniques of reconstruction, and the results are variable. In this present study, we have analyzed a technique in which we used a single layer full thickness duct to mucosa pancreatojejunostomy. Among the 25 subjects in this study, there was only one case of one mortality due to drug-induced cardiac arrhythmia, and no mortality secondary to pancreas-specific complications were reported. The present study was a pilot study compared with historical controls, where these results were comparable to the historical data reported earlier as well as our own historical data of two-layered anastamosis. The results of this pilot study supported our concept of single layer full thickness duct to mucosa anastamosis being least traumatic to the pancreas and having an equal efficacy to that other conventional techniques.</p>","PeriodicalId":45335,"journal":{"name":"Journal of Experimental Therapeutics and Oncology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2019-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"37495263","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Could there be any role of thiol disulphide homeostasis and ischemia modified albumin in the pathogenesis of endometrial polyps? 在子宫内膜息肉的发病机制中,巯基二硫醚稳态和缺血修饰白蛋白是否有作用?
Q3 Pharmacology, Toxicology and Pharmaceutics Pub Date : 2019-12-01
Gulnur Ozaksit, Aytekin Tokmak, Arzu Kosem, Meryem Kuru-Pekcan, Ozcan Erel

Objective: We searched thiol/disulphide homeostasis and ischemia modified albumin (IMA) in patients with and without endometrial polyp (EP) to evaluate whether there is an association between serum oxidative stress markers and EPs.

Methods: A total of 87 women were enrolled into this study. All patients were evaluated with office hysteroscopy, and then those with EPs underwent operative hysteroscopy. 43 of these women had pathologically confirmed EPs (study group) and 44 had not (control group). Fasting blood samples were obtained from the antecubital vein before the procedure in all women. Thiol/disulphide levels were analyzed with a newly developed method by Erel et al. IMA measurement was performed using an indirect method based on the colorimetric assay as previously defined.

Results: There were no significant differences between the 2 groups in terms of demographic characteristics including age, body mass index, and past obstetric history. Similarly no significant difference was observed regarding infertility ratio and smoking status. Native thiol, total thiol, and disulphide levels were found to be 263.6±63.3 µmol/l vs. 280.9±63.8 µmol/l (p:0.208), 296.9±64.9 µmol/l vs. 315.2±67.3 µmol/l (p:0.202), and 16.6±6.5 µmol/l vs.17.1±7.8 µmol/l ( p:0.759) in the study and control groups, respectively. There was also no significant difference with regard to serum IMA level (46.5±12.1 vs. 44.9±12.6; p: 0.539).

Conclusion: Serum thiol/disulphide homeostasis and IMA levels have no significant effect in the pathogenesis of EPs.

目的:研究有或无子宫内膜息肉(EP)患者的硫醇/二硫稳态和缺血修饰白蛋白(IMA)水平,以评估血清氧化应激标志物与EP之间是否存在关联。方法:共87名女性纳入本研究。所有患者均行宫腔镜检查,EPs患者行手术宫腔镜检查。其中病理确诊EPs 43例(研究组),未确诊EPs 44例(对照组)。手术前,所有女性的空腹血样均取自肘前静脉。用Erel等人新开发的方法分析硫醇/二硫化物水平。IMA测量使用基于先前定义的比色法的间接方法进行。结果:两组在年龄、体重指数、既往产科史等人口学特征方面无显著差异。同样,在不孕率和吸烟状况方面也没有观察到显著差异。研究和对照组的天然硫醇、总硫醇和二硫化物水平分别为263.6±63.3µmol/l和280.9±63.8µmol/l (p:0.208), 296.9±64.9µmol/l和315.2±67.3µmol/l (p:0.202), 16.6±6.5µmol/l和17.1±7.8µmol/l (p: 0.759)。血清IMA水平(46.5±12.1∶44.9±12.6;p: 0.539)。结论:血清硫醇/二硫稳态和IMA水平在EPs发病过程中无显著影响。
{"title":"Could there be any role of thiol disulphide homeostasis and ischemia modified albumin in the pathogenesis of endometrial polyps?","authors":"Gulnur Ozaksit,&nbsp;Aytekin Tokmak,&nbsp;Arzu Kosem,&nbsp;Meryem Kuru-Pekcan,&nbsp;Ozcan Erel","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Objective: </strong>We searched thiol/disulphide homeostasis and ischemia modified albumin (IMA) in patients with and without endometrial polyp (EP) to evaluate whether there is an association between serum oxidative stress markers and EPs.</p><p><strong>Methods: </strong>A total of 87 women were enrolled into this study. All patients were evaluated with office hysteroscopy, and then those with EPs underwent operative hysteroscopy. 43 of these women had pathologically confirmed EPs (study group) and 44 had not (control group). Fasting blood samples were obtained from the antecubital vein before the procedure in all women. Thiol/disulphide levels were analyzed with a newly developed method by Erel et al. IMA measurement was performed using an indirect method based on the colorimetric assay as previously defined.</p><p><strong>Results: </strong>There were no significant differences between the 2 groups in terms of demographic characteristics including age, body mass index, and past obstetric history. Similarly no significant difference was observed regarding infertility ratio and smoking status. Native thiol, total thiol, and disulphide levels were found to be 263.6±63.3 µmol/l vs. 280.9±63.8 µmol/l (p:0.208), 296.9±64.9 µmol/l vs. 315.2±67.3 µmol/l (p:0.202), and 16.6±6.5 µmol/l vs.17.1±7.8 µmol/l ( p:0.759) in the study and control groups, respectively. There was also no significant difference with regard to serum IMA level (46.5±12.1 vs. 44.9±12.6; p: 0.539).</p><p><strong>Conclusion: </strong>Serum thiol/disulphide homeostasis and IMA levels have no significant effect in the pathogenesis of EPs.</p>","PeriodicalId":45335,"journal":{"name":"Journal of Experimental Therapeutics and Oncology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2019-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"37495264","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Journal of Experimental Therapeutics and Oncology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1